Compare RS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RS | NBIX |
|---|---|---|
| Founded | 1939 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 15.2B |
| IPO Year | 1994 | 1996 |
| Metric | RS | NBIX |
|---|---|---|
| Price | $297.82 | $141.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 21 |
| Target Price | ★ $317.25 | $176.19 |
| AVG Volume (30 Days) | 338.6K | ★ 995.7K |
| Earning Date | 10-22-2025 | 02-05-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | ★ 13.63 | 4.19 |
| Revenue | ★ $13,922,300,000.00 | $2,682,700,000.00 |
| Revenue This Year | $5.75 | $23.76 |
| Revenue Next Year | $4.42 | $18.01 |
| P/E Ratio | ★ $21.76 | $33.84 |
| Revenue Growth | N/A | ★ 19.61 |
| 52 Week Low | $250.07 | $84.23 |
| 52 Week High | $347.44 | $160.18 |
| Indicator | RS | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 63.56 | 41.93 |
| Support Level | $284.91 | $151.09 |
| Resistance Level | $300.72 | $155.55 |
| Average True Range (ATR) | 6.14 | 4.45 |
| MACD | 1.20 | -1.54 |
| Stochastic Oscillator | 76.65 | 13.66 |
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.